{{Rsnum
|rsid=2238476
|Gene=ABCC1
|Chromosome=16
|position=16120015
|Orientation=minus
|GMAF=0.06612
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCC1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 87.6 | 12.4 | 0.0
| HCB | 91.2 | 8.8 | 0.0
| JPT | 88.5 | 10.6 | 0.9
| YRI | 95.2 | 4.8 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 91.2 | 8.8 | 0.0
| CHD | 95.4 | 4.6 | 0.0
| GIH | 91.1 | 8.9 | 0.0
| LWK | 92.7 | 7.3 | 0.0
| MEX | 72.4 | 24.1 | 3.4
| MKK | 98.1 | 1.9 | 0.0
| TSI | 92.2 | 7.8 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2238476
|Name_s=
|Gene_s=ABCC1
|Feature=
|Evidence=PubMed ID:18256692
|Annotation=SNP influences the efficacy of methotrexate in patients with psoriasis.
|Drugs=methotrexate
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161149203
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2238476
|overall_frequency_n=3
|overall_frequency_d=128
|overall_frequency=0.0234375
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}